Evidence map›Paper›PMID 41052005›Full record

ArticleJournal of visualized experiments : JoVE2025

Optimized Analysis of Proteins from Xenopus Oocytes and Embryos by Immunoblotting.

Charlotte R Kanzler, Michael D Sheets

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Charlotte R KanzlerDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health; kanzler@wisc.edu.
Michael D SheetsDepartment of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health; mdsheets@wisc.edu.

Funding

Mechanisms of mRNA-selective control by Bicaudal-CR01GM152615 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Michael D Sheets · 2024 to 2026
$1.6M
Regulation of cell fates by the Bicaudal-C translational repressorR01HD091921 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI SHEETS, MICHAEL D · 2018 to 2022
$1.5M
NICHD NIH HHS R01 HD091921NIGMS NIH HHS R01 GM152615
6 · The paper itself

Abstract

Analysis of proteins by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblotting (western blotting) is a vital part of the molecular biologist's toolkit. This technique separates a complex protein mixture by molecular weight and then assays the presence of target proteins using specific antibodies. Immunoblotting has a variety of applications. Examples include use as a targeted approach to study protein-protein interactors or as a control to confirm expression or depletion of protein targets. However, the successful execution of immunoblotting requires complicated, multistep experiments. Protocols must be optimized for each organism, target protein, and application. Therefore, knowledge gaps exist for the use of immunoblots in many models, including the model frog Xenopus laevis. Due to their large size, abundant material for biochemical experiments, and facile handling, X. laevis oocytes and embryos have been vital for studying principles of translational control. However, this species lacks specific protocols for robust and routine immunoblotting. Here, we offer an in-depth protocol for western blotting optimized for samples from multiple Xenopus developmental stages. We then analyze translational regulators across development.

Indexed as

Blotting, WesternEmbryo, NonmammalianOocytesXenopus laevisXenopus ProteinsAnimalsElectrophoresis, Polyacrylamide GelFemaleXenopus Proteins

Identifiers

PMID41052005
PMCPMC12955539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.